$1.19
0.021.71%
At Close: -
$1.21
0.021.68%
After Hours: Sep 20, 6:19 PM EDT
15 minutes delayed
CytomX Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of CytomX Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $-0.08 | $-0.14 | 42.9 % |
Mar 2024 | 2024-05-08 | $0.17 | $-0.06 | 383.3 % |
Dec 2023 | 2024-03-11 | $0.01 | $-0.03 | 133.3 % |
Sep 2023 | 2023-11-07 | $0.04 | $-0.19 | 121.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $25.12M | $19.99M | 25.6 % |
Mar 2024 | 2024-05-08 | $41.46M | $22.02M | 88.3 % |
Dec 2023 | 2024-03-11 | $26.61M | $21.04M | 26.5 % |
Sep 2023 | 2023-11-07 | $26.38M | $14.14M | 86.6 % |
CytomX Therapeutics (CTMX) is scheduled to report earnings on November 5, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
The Actual EPS was $-0.08, which beat the estimate of $-0.14.
The Actual Revenue was $25.1M, which beat the estimate of $20M.
Browse earnings estimates, EPS, and revenue on all stocks.